APA

Varadan V., Kamalakaran S., Gilmore H., Banerjee N., Janevski A., Miskimen K. L. S., Williams N., Basavanhalli A., Madabhushi A., Lezon-Geyda K., Bossuyt V., Lannin D. R., Abu-Khalaf M., Sikov W., Dimitrova N. & Harris L. N. (20160601). Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers. : International journal of cancer.

Chicago

Varadan Vinay, Kamalakaran Sitharthan, Gilmore Hannah, Banerjee Nilanjana, Janevski Angel, Miskimen Kristy L S, Williams Nicole, Basavanhalli Ajay, Madabhushi Anant, Lezon-Geyda Kimberly, Bossuyt Veerle, Lannin Donald R, Abu-Khalaf Maysa, Sikov William, Dimitrova Nevenka and Harris Lyndsay N. 20160601. Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers. : International journal of cancer.

Harvard

Varadan V., Kamalakaran S., Gilmore H., Banerjee N., Janevski A., Miskimen K. L. S., Williams N., Basavanhalli A., Madabhushi A., Lezon-Geyda K., Bossuyt V., Lannin D. R., Abu-Khalaf M., Sikov W., Dimitrova N. and Harris L. N. (20160601). Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers. : International journal of cancer.

MLA

Varadan Vinay, Kamalakaran Sitharthan, Gilmore Hannah, Banerjee Nilanjana, Janevski Angel, Miskimen Kristy L S, Williams Nicole, Basavanhalli Ajay, Madabhushi Anant, Lezon-Geyda Kimberly, Bossuyt Veerle, Lannin Donald R, Abu-Khalaf Maysa, Sikov William, Dimitrova Nevenka and Harris Lyndsay N. Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers. : International journal of cancer. 20160601.